(Q33955126)

30 July 2017

1 reference

title

Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites (English)

1 reference

30 July 2017

1 reference

Smith MT

1

1 reference

30 July 2017

language of work or name

1 reference

1 July 2000

1 reference

Clinical and Experimental Pharmacology and Physiology

30 July 2017

published in

1 reference

30 July 2017

volume

27

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

524-528

1 reference

Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Epidural and intravenous opioid-induced neuroexcitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Morphine-induced myoclonic movements in a pediatric pain patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Morphine and enkephalin: analgesic and epileptic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Differential behavioral effects induced by intrathecal microinjection of opiates: Comparison of convulsive and cataleptic effects produced by morphine, methadone, andd-Ala2-methionine-enkephalinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Opiate alkaloids antagonize postsynaptic glycine and GABA responses: correlation with convulsant action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

Effects of morphine-3-glucuronide and morphine on the K+-evoked release of [3H]-glutamic acid and [14C]-gamma-aminobutyric acid from rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2000.03290.X

10.1046/J.1440-1681.2000.03290.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference